A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of diclazuril capsules as a treatment for cryptosporidial
related diarrhea in AIDS patients who have been treated in the double-blind study # JRD
64,433/1101 and have relapsed, or de-novo patients who have been diagnosed with
cryptosporidial related diarrhea and who meet the inclusion and exclusion criteria of this
protocol.